Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2025

Net Loss Per Share [Abstract]

Schedule of Anti-dilutive Shares

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2025 and 2024 are as follows:

	Three months ended March 31, 2025 (Shares)		Three months ended March 31,  2024 (Shares)
Convertible debt		1,978,891,288		15,232,285
Stock options		2,113,335		1,520,002
Warrants to purchase shares of Common Stock		993,777,942		11,187,530
		2,974,782,565		27,939,817